Arecor Therapeutics plc

LSE AREC.L

Arecor Therapeutics plc Dividend Yield on January 24, 2025: 0.00%

Arecor Therapeutics plc Dividend Yield is 0.00% on January 24, 2025, a 0.00% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.
  • Arecor Therapeutics plc 52-week high Dividend Yield is 0.00% on January 24, 2025, which is 0.00% below the current Dividend Yield.
  • Arecor Therapeutics plc 52-week low Dividend Yield is 0.00% on January 24, 2025, which is 0.00% below the current Dividend Yield.
  • Arecor Therapeutics plc average Dividend Yield for the last 52 weeks is 0.00%.
Key data
Date Dividend Yield Free Cash Flow Yield Earnings Yield Enterprise Value (EV)
Market news
SV Wall Street
LSE: AREC.L

Arecor Therapeutics plc

CEO Dr. Sarah Jennifer Howell Ph.D.
IPO Date June 3, 2021
Location United Kingdom
Headquarters Chesterford Research Park
Employees 50
Sector Health Care
Industries
Pharmaceuticals Biotechnology
Description

Arecor Therapeutics PLC, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products. It is developing AT247, an ultra-rapid acting insulin for patients with Type I and Type II diabetics; and AT278, an ultra-concentrated rapid acting insulin formulation that has been designed to accelerate the absorption of insulin post injection. The company was founded in 2007 and is headquartered in Little Chesterford, the United Kingdom.

Similar companies

POLB.L

Poolbeg Pharma PLC

USD 0.07

3.89%

StockViz Staff

January 28, 2025

Any question? Send us an email